RDP58 inhibits T cell-mediated bladder inflammation in an autoimmune cystitis model
- 26 December 2007
- journal article
- Published by Elsevier in Journal of Autoimmunity
- Vol. 30 (4) , 257-265
- https://doi.org/10.1016/j.jaut.2007.10.005
Abstract
No abstract availableKeywords
This publication has 64 references indexed in Scilit:
- Disturbances in B- and T-cell homeostasis in rheumatoid arthritis: Suggested relationships with antigen-driven immune responsesJournal of Autoimmunity, 2007
- Balancing autoaggressive and protective T cell responsesJournal of Autoimmunity, 2007
- Recent developments of intravesical therapy of painful bladder syndrome/interstitial cystitis: a reviewCurrent Opinion in Urology, 2006
- MODULATING BLADDER NEURO-INFLAMMATION: RDP58, A NOVEL ANTI-INFLAMMATORY PEPTIDE, DECREASES INFLAMMATION AND NERVE GROWTH FACTOR PRODUCTION IN EXPERIMENTAL CYSTITISJournal of Urology, 2005
- Oral RDP58 Allows CPT-11 Dose Intensification for Enhanced Tumor Response by Decreasing Gastrointestinal ToxicityClinical Cancer Research, 2004
- Voiding dysfunction in women with systemic lupus erythematosusArthritis & Rheumatism, 2004
- Mast cells mediate substance P-induced bladder inflammation through an NK1receptor-independent mechanismAmerican Journal of Physiology-Renal Physiology, 2002
- Mast Cell Activation Triggers a Urothelial Inflammatory Response Mediated by Tumor Necrosis Factor-αJournal of Urology, 2002
- Inflammatory Cell Types and Clinical Features of Interstitial CystitisJournal of Urology, 1997
- Role of the Immune Response in Interstitial CystitisClinical Immunology and Immunopathology, 1995